Cover Image
Market Research Report

Cell Signaling Market by Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, Cancer, Immunology) - Global Forecast to 2022

Published by MarketsandMarkets Product code 503213
Published Content info 215 Pages
Immediate Delivery Available
Price
Back to Top
Cell Signaling Market by Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, Cancer, Immunology) - Global Forecast to 2022
Published: May 12, 2017 Content info: 215 Pages
Description

The cell signaling market is expected to reach USD 3.51 billion by 2022 from USD 2.53 billion in 2017, at a CAGR of 6.8%. Factors such as increasing incidence of various chronic diseases; rising funding for cell-based research activities; introduction of innovative and advanced instruments; and growing biotech and biopharmaceutical industries are driving the global cell signaling market.

The cell signaling market is categorized based on type, product, technology, pathway, application, and region. The type segment includes endocrine, paracrine, autocrine, juxtacrine, and other types (neuronal and intracrine signaling). The endocrine segment is estimated to account the largest share of the cell signaling market in 2017.

By product, the cell signaling market is categorized into consumables (antibodies, reagents, assay kits and other consumables) and instruments. In 2017, the consumables segment is estimated to account the largest share of the market.

The technology segment of the cell signaling market includes microscopy, western blotting, immunohistochemistry (IHC), flow cytometry, enzyme-linked immunosorbent assay (ELISA), mass spectrometry, and other technologies (immunofluorescence and immunoprecipitation). The microscopy segment is estimated to account for the largest share of the cell signaling market in 2017.

On the basis of the pathway, the cell signaling market is categorized into Akt, AMP-activated protein kinase (AMPK), ErbB/HER, Hedgehog (Hh), Janus kinase and signal transducer and activator of transcription (JAK/STAT), NF-KB, Notch, and other signaling pathways. In 2017, the Akt segment is estimated to account the largest share of the cell signaling market.

The application segment of cell signaling market includes research applications (cancer research, immunology research, stem cells research, and other research applications) and medical applications. The research applications segment is estimated to account for the largest share of the cell signaling market in 2017.

Geographically, the cell signaling market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).

The major players in the cell signaling market include Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), QIAGEN N.V. (Netherlands), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Promega Corporation (U.S.), PerkinElmer Inc. (U.S.), Bio-Techne Corporation (U.S.), and Abcam plc (U.K.)

Research Coverage:

Apart from comprehensive geographic analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles also comprise of product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. This market research data can help key players and new entrants make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the cell signaling market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned strategies to strengthening their shares in the cell signaling market.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios of the top players in the cell signaling market. The report analyzes the cell signaling market, by type, product, technology, pathway, application, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the cell signaling market
  • Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of the leading players in the cell signaling market
  • Market Development: Comprehensive information about emerging markets. This report analyses the cell signaling market across geographies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell signaling market
Table of Contents
Product Code: BT 5257

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY DATA
    • 2.1.1. KEY DATA FROM SECONDARY SOURCES
  • 2.2. PRIMARY DATA
    • 2.2.1. KEY DATA FROM PRIMARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CELL SIGNALING: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: CELL SIGNALING MARKET, BY SIGNALING TYPE & REGION (2017)
  • 4.3. CELL SIGNALING MARKET, BY PATHWAY, 2017-2022
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE CELL SIGNALING MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising incidence of chronic diseases
      • 5.2.1.2. Availability of funding for cell-based research
      • 5.2.1.3. Technological advancements in cell-based research instruments
      • 5.2.1.4. Growth of end-use industries
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of cell signaling systems
      • 5.2.2.2. Ethical issues related to embryonic stem cell signaling research
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Emergence of microfluidics in cell biology research
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Complexities related to antibody and reagent development

6. GLOBAL CELL SIGNALING MARKET, BY SIGNALING TYPE

  • 6.1. INTRODUCTION
  • 6.2. ENDOCRINE SIGNALING
  • 6.3. PARACRINE SIGNALING
  • 6.4. AUTOCRINE SIGNALING
  • 6.5. JUXTACRINE SIGNALING
  • 6.6. OTHER SIGNALING TYPES

7. GLOBAL CELL SIGNALING MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. CONSUMABLES
    • 7.2.1. ANTIBODIES
    • 7.2.2. REAGENTS
    • 7.2.3. ASSAY KITS
    • 7.2.4. OTHER CONSUMABLES
  • 7.3. INSTRUMENTS

8. GLOBAL CELL SIGNALING MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. MICROSCOPY
  • 8.3. FLOW CYTOMETRY
  • 8.4. MASS SPECTROMETRY
  • 8.5. WESTERN BLOTTING
  • 8.6. ELISA
  • 8.7. IMMUNOHISTOCHEMISTRY
  • 8.8. OTHER TECHNOLOGIES

9. GLOBAL CELL SIGNALING MARKET, BY PATHWAY

  • 9.1. INTRODUCTION
  • 9.2. AKT SIGNALING PATHWAY
  • 9.3. AMPK SIGNALING PATHWAY
  • 9.4. ERBB/HER SIGNALING PATHWAY
  • 9.5. HEDGEHOG SIGNALING PATHWAY
  • 9.6. JAK/STAT SIGNALING PATHWAY
  • 9.7. NOTCH SIGNALING PATHWAY
  • 9.8. NF-KB SIGNALING PATHWAY
  • 9.9. OTHER SIGNALING PATHWAYS

10. CELL SIGNALING MARKET, BY APPLICATION

  • 10.1. INTRODUCTION
  • 10.2. RESEARCH APPLICATIONS
    • 10.2.1. CANCER RESEARCH
    • 10.2.2. IMMUNOLOGY RESEARCH
    • 10.2.3. STEM CELLS RESEARCH
    • 10.2.4. OTHER RESEARCH APPLICATIONS
  • 10.3. MEDICAL APPLICATIONS

11. GLOBAL CELL SIGNALING MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. FRANCE
    • 11.3.3. U.K.
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. REST OF EUROPE (ROE)
  • 11.4. ASIA
    • 11.4.1. CHINA
    • 11.4.2. JAPAN
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA (ROA)
  • 11.5. REST OF THE WORLD (ROW)

12. COMPETITIVE LANDSCAPE

  • 12.1. INTRODUCTION
  • 12.2. VENDOR DIVE OVERVIEW
    • 12.2.1. VANGUARDS
    • 12.2.2. INNOVATORS
    • 12.2.3. DYNAMIC PLAYERS
    • 12.2.4. EMERGING PLAYERS
  • 12.3. COMPETITIVE BENCHMARKING
    • 12.3.1. PRODUCT OFFERINGS (FOR ALL 25 PLAYERS)
    • 12.3.2. BUSINESS STRATEGY (FOR ALL 25 PLAYERS)

Top 25 companies analyzed for this study are - Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Promega Corporation (U.S.), Bio-Techne Corporation (U.S.), Abcam plc (U.K.), Miltenyi Biotec (Germany), Full Moon BioSystems, Inc. (U.S.), Cell Biolabs, Inc. (U.S.), Cisbio Bioassays (France), Rockland Immunochemicals Inc. (U.S.), BioVision, Inc. (U.S.), Tonbo Biosciences (U.S.), BPS Bioscience, Inc. (U.S.), StressMarq Biosciences Inc. (U.S.), Abeomics, Inc. (U.S.), Sino Biological, Inc. (U.S.), RayBiotech, Inc. (U.S.), MEDICAL & BIOLOGICAL LABORATORIES CO.,LTD. (Japan), and Santa Cruz Biotechnology, Inc. (U.S.)

13. COMPANY PROFILES (OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*

  • 13.1. MERCK KGAA
  • 13.2. THERMO FISHER SCIENTIFIC INC.
  • 13.3. BECTON, DICKINSON AND COMPANY
  • 13.4. BECKMAN COULTER INC. (A SUBSIDIARY OF DANAHER CORPORATION)
  • 13.5. BIO-RAD LABORATORIES, INC.
  • 13.6. PERKINELMER, INC
  • 13.7. QIAGEN N.V.
  • 13.8. CELL SIGNALING TECHNOLOGY, INC.
  • 13.9. PROMEGA CORPORATION
  • 13.10. BIO-TECHNE CORPORATION

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

14. KEY INNOVATORS

  • 14.1. CISBIO BIOASSAYS
    • 14.1.1. INNOVATIONS
  • 14.2. MILTENYI BIOTEC
    • 14.2.1. INNOVATIONS
  • 14.3. CELL BIOLABS, INC.
    • 14.3.1. INNOVATIONS

15. APPENDIX

  • 15.1. INDUSTRY INSIGHTS
  • 15.2. DISCUSSION GUIDE
  • 15.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 15.5. AVAILABLE CUSTOMIZATIONS
  • 15.6. RELATED REPORTS
  • 15.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: CELL SIGNALING: MARKET SNAPSHOT
  • TABLE 2: PROJECTED INCREASE IN CANCER PATIENTS, BY TYPE (2012, 2015, AND 2035)
  • TABLE 3: CELL SIGNALING MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 4: ENDOCRINE SIGNALING MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: PARACRINE SIGNALING MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: AUTOCRINE SIGNALING MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: JUXTACRINE SIGNALING MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: OTHER CELL SIGNALING TYPES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 10: CELL SIGNALING CONSUMABLES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 12: CELL SIGNALING ANTIBODIES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: CELL SIGNALING REAGENTS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: CELL SIGNALING ASSAY KITS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: OTHER CELL SIGNALING CONSUMABLES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: CELL SIGNALING INSTRUMENTS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 18: CELL SIGNALING MARKET SIZE FOR MICROSCOPY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: CELL SIGNALING MARKET SIZE FOR FLOW CYTOMETRY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: CELL SIGNALING MARKET SIZE FOR MASS SPECTROMETRY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: CELL SIGNALING MARKET SIZE FOR WESTERN BLOTTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: CELL SIGNALING MARKET SIZE FOR ELISA, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: CELL SIGNALING MARKET SIZE FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: CELL SIGNALING MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 26: AKT SIGNALING PATHWAY MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: AMPK SIGNALING PATHWAY MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: ERBB/HER SIGNALING PATHWAY MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: HEDGEHOG SIGNALING PATHWAY MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: JAK/STAT SIGNALING PATHWAY MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: NOTCH SIGNALING PATHWAY MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: NF-KB SIGNALING PATHWAY MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: OTHER SIGNALING PATHWAYS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 34: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 35: CELL SIGNALING MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 36: CELL SIGNALING MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 37: CELL SIGNALING MARKET SIZE FOR CANCER RESEARCH, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 38: CELL SIGNALING MARKET SIZE FOR IMMUNOLOGY RESEARCH, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 39: CELL SIGNALING MARKET SIZE FOR STEM CELLS RESEARCH, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 40: CELL SIGNALING MARKET SIZE FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: CELL SIGNALING MARKET SIZE FOR MEDICAL APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 42: CELL SIGNALING MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 43: NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 45: NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 46: NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 47: NORTH AMERICA: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 49: NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 50: NORTH AMERICA: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: U.S.: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: U.S.: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 53: U.S.: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 54: U.S.: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: U.S.: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 56: U.S.: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 57: U.S.: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: CANADA: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: CANADA: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 60: CANADA: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 61: CANADA: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 62: CANADA: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 63: CANADA: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 64: CANADA: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: EUROPE: CELL SIGNALING MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 66: EUROPE: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: EUROPE: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 68: EUROPE: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 69: EUROPE: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 70: EUROPE: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 71: NORTH AMERICA: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 72: EUROPE: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 73: GERMANY: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 74: GERMANY: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 75: GERMANY: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 76: GERMANY: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: GERMANY: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 78: GERMANY: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 79: GERMANY: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 80: FRANCE: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 81: FRANCE: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 82: FRANCE: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 83: FRANCE: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 84: FRANCE: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 85: FRANCE: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 86: FRANCE: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 87: U.K.: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 88: U.K.: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 89: U.K.: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 90: U.K.: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 91: U.K.: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 92: U.K.: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 93: U.K.: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 94: ITALY: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 95: ITALY: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 96: ITALY: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 97: ITALY: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 98: ITALY: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 99: ITALY: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 100: ITALY: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 101: SPAIN: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 102: SPAIN: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 103: SPAIN: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 104: SPAIN: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 105: SPAIN: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 106: SPAIN: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 107: SPAIN: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 108: ROE: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 109: ROE: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 110: ROE: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 111: ROE: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 112: ROE: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 113: ROE: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 114: ROE: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 115: ASIA: CELL SIGNALING MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 116: ASIA: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 117: ASIA: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 118: ASIA: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 119: ASIA: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 120: ASIA: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 121: ASIA: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 122: ASIA: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 123: CHINA: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 124: CHINA: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 125: CHINA: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 126: CHINA: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 127: CHINA: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 128: CHINA: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 129: CHINA: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 130: JAPAN: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 131: JAPAN: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 132: JAPAN: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 133: JAPAN: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 134: JAPAN: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 135: JAPAN: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 136: JAPAN: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 137: INDIA: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 138: INDIA: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 139: INDIA: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 140: INDIA: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 141: INDIA: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 142: INDIA: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 143: INDIA: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 144: ROA: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 145: ROA: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 146: ROA: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 147: ROA: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 148: ROA: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 149: ROA: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 150: ROA: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 151: ROW: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2015-2022 (USD MILLION)
  • TABLE 152: ROW: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2015-2022 (USD MILLION)
  • TABLE 153: ROW: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 154: ROW: CELL SIGNALING CONSUMABLES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 155: ROW: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 156: ROW: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 157: ROW: CELL SIGNALING RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: CELL SIGNALING MARKET: BOTTOM-UP APPROACH
  • FIGURE 3: TOP-DOWN APPROACH
  • FIGURE 4: DATA TRIANGULATION METHODOLOGY
  • FIGURE 5: CELL SIGNALING MARKET SIZE, BY SIGNALING TYPE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 6: CELL SIGNALING MARKET SIZE, BY PATHWAY, 2017 VS. 2022 (USD BILLION)
  • FIGURE 7: CELL SIGNALING MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD BILLION)
  • FIGURE 8: CELL SIGNALING MARKET SIZE, BY TECHNOLOGY, 2017 VS. 2022 (USD BILLION)
  • FIGURE 9: CELL SIGNALING MARKET SIZE, BY APPLICATION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 10: CELL SIGNALING MARKET SIZE, BY REGION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 11: GROWING PREVALENCE OF CHRONIC DISEASES AND AVAILABILITY OF FUNDING FOR CELL-BASED RESEARCH ARE DRIVING THE GROWTH OF THE CELL SIGNALING MARKET DURING THE FORECAST PERIOD
  • FIGURE 12: NORTH AMERICA & ENDOCRINE SEGMENTS ARE ESTIMATED TO COMMAND THE LARGEST MARKET SHARE IN 2017
  • FIGURE 13: AKT SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 14: ASIA TO REGISTER THE HIGHEST CAGR BETWEEN 2017 & 2022
  • FIGURE 15: CELL SIGNALING MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 16: DIABETES CASES, 2015 VS. 2040 (MILLION)
  • FIGURE 17: ENDOCRINE SIGNALING SEGMENT TO DOMINATE THE CELL SIGNALING MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: NORTH AMERICA TO DOMINATE THE ENDOCRINE SIGNALING MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: NORTH AMERICA TO DOMINATE THE AUTOCRINE SIGNALING MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: CONSUMABLES TO DOMINATE THE CELL SIGNALING MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: ANTIBODIES TO DOMINATE THE CELL SIGNALING CONSUMABLES MARKET IN 2017-2022
  • FIGURE 22: NORTH AMERICA TO DOMINATE THE CELL SIGNALING INSTRUMENTS MARKET DURING 2017-2022
  • FIGURE 23: MICROSCOPY SEGMENT TO DOMINATE THE CELL SIGNALING TECHNOLOGY MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: AKT PATHWAY SEGMENT TO DOMINATE THE CELL SIGNALING MARKET IN 2017-2022
  • FIGURE 25: RESEARCH APPLICATIONS SEGMENT WILL CONTINUE TO DOMINATE THE CELL SIGNALING MARKET IN 2022
  • FIGURE 26: ASIAN CELL SIGNALING MARKET TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 27: NORTH AMERICA: CANCER INCIDENCE & MORTALITY, 2012-2035
  • FIGURE 28: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 29: U.S.: CANCER INCIDENCE & MORTALITY, 2012-2035
  • FIGURE 30: ENDOCRINE SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. CELL SIGNALING MARKET IN 2017
  • FIGURE 31: CANADA: CANCER INCIDENCE & MORTALITY, 2012-2035
  • FIGURE 32: EUROPE: CANCER INCIDENCE & MORTALITY, 2012-2035
  • FIGURE 33: EUROPE: MARKET SNAPSHOT
  • FIGURE 34: GERMANY: CANCER INCIDENCE & MORTALITY, 2012-2035
  • FIGURE 35: GERMANY: REVENUE & R&D EXPENDITURES OF MAJOR BIOTECHNOLOGY COMPANIES, 2012-2015 (USD BILLION)
  • FIGURE 36: AKT SEGMENT TO REGISTER THE HIGHEST CAGR IN THE GERMAN CELL SIGNALING MARKET DURING THE FORECAST PERIOD
  • FIGURE 37: FRANCE: CANCER INCIDENCE & MORTALITY, 2012-2035
  • FIGURE 38: U.K.: CANCER INCIDENCE & MORTALITY, 2012-2035
  • FIGURE 39: ITALY: CANCER INCIDENCE & MORTALITY, 2012-2035
  • FIGURE 40: SPAIN: CANCER INCIDENCE & MORTALITY, 2012-2035
  • FIGURE 41: ASIA: CANCER INCIDENCE & MORTALITY, 2012-2035
  • FIGURE 42: ASIA: MARKET SNAPSHOT
  • FIGURE 43: CHINA: CANCER INCIDENCE & MORTALITY, 2012-2035
  • FIGURE 44: JAPAN: CANCER INCIDENCE & MORTALITY, 2012-2035
  • FIGURE 45: CONSUMABLES SEGMENT TO REGISTER THE HIGHEST CAGR IN THE JAPANESE CELL SIGNALING MARKET DURING THE FORECAST PERIOD
  • FIGURE 46: INDIA: CANCER INCIDENCE & MORTALITY, 2012-2035
  • FIGURE 47: ROW: MARKET SNAPSHOT
  • FIGURE 48: DIVE CHART: CELL SIGNALING MARKET
  • FIGURE 49: MERCK KGAA: COMPANY SNAPSHOT (2016)
  • FIGURE 50: MERCK KGAA: PRODUCT OFFERING SCORECARD
  • FIGURE 51: MERCK KGAA: BUSINESS STRATEGY SCORECARD
  • FIGURE 52: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 53: THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 54: THERMO FISHER SCIENTIFIC INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 55: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016)
  • FIGURE 56: BECTON, DICKINSON AND COMPANY: PRODUCT OFFERING SCORECARD
  • FIGURE 57: BECTON, DICKINSON AND COMPANY: BUSINESS STRATEGY SCORECARD
  • FIGURE 58: DANAHER CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 59: DANAHER CORPORATION: PRODUCT OFFERING SCORECARD
  • FIGURE 60: DANAHER CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 61: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 62: BIO-RAD LABORATORIES, INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 63: BIO-RAD LABORATORIES, INC.:: BUSINESS STRATEGY SCORECARD
  • FIGURE 64: PERKINELMER, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 65: PERKINELMER, INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 66: PERKINELMER, INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 67: QIAGEN N.V.: COMPANY SNAPSHOT (2016)
  • FIGURE 68: QIAGEN N.V.: PRODUCT OFFERING SCORECARD
  • FIGURE 69: QIAGEN N.V.: BUSINESS STRATEGY SCORECARD
  • FIGURE 70: CELL SIGNALING TECHNOLOGY INC.: PRODUCT OFFERING SCORECARD
  • FIGURE 71: CELL SIGNALING TECHNOLOGY INC.: BUSINESS STRATEGY SCORECARD
  • FIGURE 72: PROMEGA CORPORATION: PRODUCT OFFERING SCORECARD
  • FIGURE 73: PROMEGA CORPORATION: BUSINESS STRATEGY SCORECARD
  • FIGURE 74: BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 75: BIO-TECHNE CORPORATION: PRODUCT OFFERING SCORECARD
  • FIGURE 76: BIO-TECHNE CORPORATION: BUSINESS STRATEGY SCORECARD
Back to Top